J.W. Cole Advisors Inc. Raises Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

J.W. Cole Advisors Inc. increased its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 7.3% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 4,437 shares of the company’s stock after acquiring an additional 302 shares during the period. J.W. Cole Advisors Inc.’s holdings in GE HealthCare Technologies were worth $343,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its position in GE HealthCare Technologies by 14.7% in the third quarter. Vanguard Group Inc. now owns 44,531,402 shares of the company’s stock worth $3,029,917,000 after acquiring an additional 5,693,244 shares during the period. Invesco Ltd. grew its position in GE HealthCare Technologies by 21.4% in the third quarter. Invesco Ltd. now owns 5,048,262 shares of the company’s stock worth $343,484,000 after acquiring an additional 889,297 shares during the period. Bank of New York Mellon Corp grew its position in GE HealthCare Technologies by 7.8% in the third quarter. Bank of New York Mellon Corp now owns 4,380,408 shares of the company’s stock worth $298,043,000 after acquiring an additional 315,808 shares during the period. Northern Trust Corp grew its position in GE HealthCare Technologies by 8.9% in the third quarter. Northern Trust Corp now owns 4,205,506 shares of the company’s stock worth $286,143,000 after acquiring an additional 342,040 shares during the period. Finally, Gates Capital Management Inc. grew its position in GE HealthCare Technologies by 17.5% in the third quarter. Gates Capital Management Inc. now owns 2,708,835 shares of the company’s stock worth $184,309,000 after acquiring an additional 402,900 shares during the period. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms have recently commented on GEHC. Argus raised their price target on GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a research report on Monday, April 1st. Morgan Stanley lifted their target price on GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a report on Monday, February 12th. HSBC initiated coverage on GE HealthCare Technologies in a research note on Thursday, February 15th. They issued a “buy” rating and a $100.00 price target on the stock. Citigroup lifted their target price on GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Finally, UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and lifted their target price for the stock from $66.00 to $88.00 in a research report on Monday, February 12th. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $95.09.

GE HealthCare Technologies Trading Up 0.6 %

Shares of GE HealthCare Technologies stock opened at $86.72 on Thursday. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.05 and a quick ratio of 0.83. GE HealthCare Technologies Inc. has a 1 year low of $62.35 and a 1 year high of $94.50. The company has a market capitalization of $39.57 billion, a P/E ratio of 28.72, a P/E/G ratio of 2.93 and a beta of 0.94. The business has a 50 day moving average price of $88.91 and a 200 day moving average price of $78.27.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share for the quarter, topping analysts’ consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The company had revenue of $5.20 billion for the quarter, compared to analyst estimates of $5.09 billion. During the same quarter in the prior year, the company posted $1.31 EPS. The business’s revenue for the quarter was up 5.3% compared to the same quarter last year. Sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be paid a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. The ex-dividend date is Thursday, April 18th. GE HealthCare Technologies’s dividend payout ratio is presently 3.97%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.